Delivery Order SPE2DB22D1106-SPE2DB24FDRW1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,916.83 Firm Fixed Price Delivery Order is for the supply of MOVIPREP POWDER PACKETS, a pharmaceutical product, with a completion date of November 20, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $9,583.11, is for the delivery of MOVIPREP powder packets, a medical supply. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $2,375.24 firm fixed price delivery order is for the provision of MOVIPREP powder packets, a specialty pharmaceutical product. This award is associated with an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a...
- This federal contract award, valued at $2,943.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order (SPE2DB25FSUZJ) for the supply of 4,568,072,824 units of MOVIPREP POWDER PACKETS. The contract has a firm fixed price and an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp also holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,765.05, is a Firm Fixed Price Delivery Order for the supply of MOVIPREP POWDER PACKETS. The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,533.27, is a delivery order for MOVIPREP powder packets. The contract has an ultimate completion date of October 13, 2023 and is a firm fixed-price type. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
- This federal contract award, valued at $5,461.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed-price pricing type, and the ultimate completion date is May 23, 2024. The contract covers the procurement of MOVIPREP POWDER PACKETS, a medical product, to support federal healthcare programs. Amerisourcebergen holds a significant Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, with a ceiling value of $2,483.32, is for the delivery of 4563637766 MOVIPREP POWDER PACKETS. The contract is a firm fixed-price delivery order with a period of performance ending on February 13, 2024. The contract was awarded on February 12, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,548.58, is for the supply of MOVIPREP POWDER PACKETS, a medical product, with a period of performance ending on April 24, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,078.80 firm fixed-price delivery order is for the provision of various pharmaceutical products and medical supplies to support the DLA Troop Support Medical. The contract has an ultimate completion date of January 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDRW1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,001.93 firm fixed-price delivery order covers the supply of MOVIPREP POWDER PACKETS, a medical product, to support DLA Troop Support Medical operations. The award is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities and veterans' healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/21/23 |